These side effects are usually temporary and tend to improve over time as your body adjusts to the medication
Martnez-Herrera B-E, Muoz-Garca M-G, Jos-Ochoa L-L, Quiroga-Morales L-A, Cervntes-Gonzlez L-M, Mireles-Ramrez M-A, et al
doi: 10.1161/CIRCULATIONAHA.125.074545 Summary Keywords cardiovascular outcomes, SGLT2 inhibitors, GLP-1 agonists, combination therapy, heart failure, renal outcomes Citation Aristizbal-Colorado D, Corredor-Rengifo D, Sierra-Castillo S, Lpez-Corredor C, Vernaza-Trujillo D-A, Weir-Restrepo D, Izquierdo-Condoy JS, Ortiz-Prado E, Rico-Fontalvo J, Gmez-Mesa J-E, Abreu-Lomba A and Rivera-Martnez W-A (2025) A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists a comprehensive review
Can You Prevent Weight Regain After Retatrutide